Skip to main content

Table 1 Correlation between JARID1B expression and clinicopathological parameter in NSCLC patients

From: Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor

Parameters JARID1B-low expression (n = 19) JARID1B-high expression (n = 53) χ2 value p value
Age (years)
 50 8 (42.1%) 20 (37.7%) 0.112 0.737
 > 50 11 (57.9%) 33 (62.3%)   
Tumor size
 2 cm 12 (63.2%) 15 (28.3%) 7.250 *0.007
 > 2 cm 7 (36.8%) 38 (71.7%)   
Differentiation
 Poor 6 (31.6%) 23 (43.4%) 0.828 0.382
 Moderate 12 (63.2%) 28 (52.8%)   
 Well 1 (5.2%) 2 (3.8%)   
LN metastasis
 Negative 16 (84.2%) 25 (47.2%) 7.827 *0.005
 Positive 3 (15.8%) 28 (52.8%)   
Stage
 I, II 14 (73.7%) 24 (45.3%) 4.527 *0.033
 III 5 (26.3%) 29 (54.7%)   
  1. *Statistically significant values